MOBX:NASDAQMobix Labs, Inc. Analysis

Mobix Labs is trading well below its 20‑day SMA of 3.41 and 50‑day SMA of 3.91, with the price at $2.55 indicating a bearish technical stance. The RSI of 40.8 suggests the stock is not yet oversold, while the MACD histogram remains negative, reinforcing the bearish momentum. Volatility is extreme at 187% over the past 30 days and beta is markedly negative (computed -2.32), implying high sensitivity to market swings and an inverse correlation pattern. Fundamental metrics are weak: revenue has contracted by 40.8%, operating margins are deeply negative, and cash flow is consistently outflowing, with a max drawdown of ‑87.9%. The balance sheet is stressed, featuring a debt‑to‑equity ratio above 140 and negligible cash reserves. Recent material news points to a potential upside catalyst – a five‑fold jump in demand for F‑22 program components and selection for a smart‑munitions anti‑drone feasibility program – but the company also announced a 1‑for‑10 reverse split to meet Nasdaq’s minimum bid price, adding short‑term uncertainty.